Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 175
Titolo Data di pubblicazione Autore(i) File
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects 1-gen-2021 Rognoni, C.; Bertolani, A.; Jommi, C.
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations? 1-gen-2021 Ronco, V.; Dilecce, M.; Lanati, E.; Canonico, P. L.; Jommi, C.
The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service 1-gen-2020 Jommi, Claudio; Cipriani, Filippo; Fanelli, Francesca; Pedone, Maria Paola; Canonica, Walter
Establishing the value of new drugs in Italy 1-gen-2020 Villa, F.; Jommi, C.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.
Implementation of Value-based Pricing for Medicines 1-gen-2020 Jommi, C.; Armeni, P.; Costa, F.; Bertolani, A.; Otto, M.
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service 1-gen-2020 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Grossi, F.; Costa, F.
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service 1-gen-2020 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Colombo, N.; Costa, F.
Patient access to oral nutritional supplements: Which policies count? 1-gen-2020 Cavazza, M.; Banks, H.; Muscaritoli, M.; Rondanelli, M.; Zandona, E.; Jommi, C.
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals 1-gen-2019 Jommi, Claudio; Cavazza, Marianna
Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti 1-gen-2019 Jommi, Claudio; Apolone, Giovanni; Cicchetti, Americo; Conte, Pierfranco; Fattore, Giovanni; Mantoan, Domenico; Marata, Annamaria; Schincariol, Paolo; Scroccaro, Giovanna; Tosolini, Francesca; Buzzetti, Giuliano
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol 1-gen-2019 Riva, S.; Bryce, J.; De Lorenzo, F.; Del Campo, L.; Di Maio, M.; Efficace, F.; Frontini, L.; Giannarelli, D.; Gitto, L.; Iannelli, E.; Jommi, C.; Montesarchio, V.; Traclo, F.; Vaccaro, C. M.; Gallo, C.; Perrone, F.
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency 1-gen-2019 Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C.
Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: analisi delle tempistiche di valutazione dellAgenzia Italiana del Farmaco 1-gen-2018 Lidonnici, Dario; Ronco, Virginia; Isernia, Martina; Lanati, Elena; Jommi, Claudio; Canonico, Pier Luigi; Genazzani, Armando A.
Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives 1-gen-2018 Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio
Patients associations and HTA for medicines: actual and future role in Italy 1-gen-2018 Jommi, Claudio; Bertolani, Arianna
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates 1-gen-2018 Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C.
The economic impact of a switch from prescription-only to nonprescription drugs in Italy 1-gen-2018 Otto, M. H.; Pillarella, C.; Jommi, C.
Managed Entry Agreements and High Cost Medicines (European Perspective) 1-gen-2018 Jommi, C.
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study 1-gen-2018 Cozzolino, M.; Bolasco, P.; Ronco, C.; Conte, G.; Mene, P.; Mereu, M. C.; Di Luca, M.; Roccatello, D.; Rosati, A.; Jommi, C.; Costanzo, A. M.; Gualberti, G.; Di Luzio Paparatti, U.; Remuzzi, G.
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study 1-gen-2018 Jommi, C.; Armeni, P.; Battista, M.; di Procolo, P.; Conte, G.; Ronco, C.; Cozzolino, M.; Costanzo, A. M.; di Luzio Paparatti, U.; Concas, G.; Remuzzi, G.
Mostrati risultati da 21 a 40 di 175
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile